Rogier M. Vos

762 total citations
19 papers, 610 citations indexed

About

Rogier M. Vos is a scholar working on Molecular Biology, Cancer Research and Ophthalmology. According to data from OpenAlex, Rogier M. Vos has authored 19 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Ophthalmology. Recurrent topics in Rogier M. Vos's work include Retinal Development and Disorders (12 papers), MicroRNA in disease regulation (5 papers) and Retinal Diseases and Treatments (4 papers). Rogier M. Vos is often cited by papers focused on Retinal Development and Disorders (12 papers), MicroRNA in disease regulation (5 papers) and Retinal Diseases and Treatments (4 papers). Rogier M. Vos collaborates with scholars based in Netherlands, France and Germany. Rogier M. Vos's co-authors include Jan Wijnholds, C. Henrique Alves, Lucie P. Pellissier, Jan Klooster, Wendy M. Aartsen, Peter M. J. Quinn, John G. Flannery, Susanne Beck, Mathias W. Seeliger and Joost Verhaagen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rogier M. Vos

19 papers receiving 602 citations

Peers

Rogier M. Vos

OPHTH

GENET

RNMI

Konstantinos Nikopoulos Switzerland

Béatrice Bocquet France

Sarah Decembrini Switzerland

Roberta Tammaro Italy

Daniela Sanges Italy

Mariateresa Pizzo Italy

Leen Abu‐Safieh Saudi Arabia

Leen Abu Safieh Saudi Arabia

Fatemeh Rajaii United States

Konstantinos Nikopoulos Switzerland

Rogier M. Vos

623 ×1.2

143 ×0.8

OPHTH

214 ×1.7

GENET

106 ×1.0

118 ×1.5

RNMI

Citations per year, relative to Rogier M. Vos Rogier M. Vos (= 1×) peers Konstantinos Nikopoulos

Countries citing papers authored by Rogier M. Vos

Since Specialization

Citations

This map shows the geographic impact of Rogier M. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier M. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier M. Vos more than expected).

Fields of papers citing papers by Rogier M. Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier M. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier M. Vos. The network helps show where Rogier M. Vos may publish in the future.

Co-authorship network of co-authors of Rogier M. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier M. Vos. A scholar is included among the top collaborators of Rogier M. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier M. Vos. Rogier M. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Duurland, Chantal L., Marion T.J. van den Bosch, Rogier M. Vos, et al.. (2024). INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death. Oncotarget. 15(1). 470–485. 6 indexed citations

Bosch, Marion T.J. van den, Sanaz Yahyanejad, Rogier M. Vos, et al.. (2023). The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis. SHILAP Revista de lepidopterología. 3. 1 indexed citations

Alves, C. Henrique, Aat A. Mulder, Peter M. J. Quinn, et al.. (2021). Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in Crb1. International Journal of Molecular Sciences. 22(7). 3563–3563. 11 indexed citations

Yahyanejad, Sanaz, Rogier M. Vos, Marion T.J. van den Bosch, et al.. (2021). Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology. Oncotarget. 12(5). 422–439. 30 indexed citations

Bosch, Marion T.J. van den, Sanaz Yahyanejad, Mir Farshid Alemdehy, et al.. (2021). Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic. Molecular Therapy — Nucleic Acids. 23. 1161–1171. 18 indexed citations

Kotecki, Nuria, Frans L. Opdam, Debbie Robbrecht, et al.. (2021). Phase I/Ib study with INT-1B3, a novel LNP-formulated micro-RNA (miR-193a-3p mimic) therapeutic for patients with advanced solid cancer.. Journal of Clinical Oncology. 39(15_suppl). TPS2666–TPS2666. 10 indexed citations

Vos, Rogier M., et al.. (2020). AAV-CRB2 protects against vision loss in an inducible CRB1 retinitis pigmentosa mouse model. Molecular Therapy — Methods & Clinical Development. 20. 423–441. 19 indexed citations

Quinn, Peter M. J., Aat A. Mulder, C. Henrique Alves, et al.. (2019). Human iPSC-Derived Retinas Recapitulate the Fetal CRB1 CRB2 Complex Formation and Demonstrate that Photoreceptors and Müller Glia Are Targets of AAV5. Stem Cell Reports. 12(5). 906–919. 70 indexed citations

Yahyanejad, Sanaz, Iman J. Schultz, Monica Raimo, et al.. (2018). Abstract 4405: Pharmacologic profile of INT-1B3: A novel synthetic microRNA 193a-3p mimic for therapeutic intervention in oncology. Cancer Research. 78(13_Supplement). 4405–4405. 3 indexed citations

10.

Pellissier, Lucie P., et al.. (2017). AAV Serotype Testing on Cultured Human Donor Retinal Explants. Methods in molecular biology. 1715. 275–288. 10 indexed citations

11.

Pellissier, Lucie P., Peter M. J. Quinn, C. Henrique Alves, et al.. (2015). Gene therapy into photoreceptors and Müller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models. Human Molecular Genetics. 24(11). 3104–3118. 63 indexed citations

12.

Alves, C. Henrique, Lucie P. Pellissier, Rogier M. Vos, et al.. (2014). Targeted ablation of Crb2 in photoreceptor cells induces retinitis pigmentosa. SPIRE - Sciences Po Institutional REpository. 41 indexed citations

13.

Pellissier, Lucie P., Robert M. Hoek, Rogier M. Vos, et al.. (2014). Specific tools for targeting and expression in Müller glial cells. Molecular Therapy — Methods & Clinical Development. 1. 14009–14009. 44 indexed citations

14.

Pellissier, Lucie P., C. Henrique Alves, Peter M. J. Quinn, et al.. (2013). Targeted Ablation of Crb1 and Crb2 in Retinal Progenitor Cells Mimics Leber Congenital Amaurosis. PLoS Genetics. 9(12). e1003976–e1003976. 65 indexed citations

15.

Alves, C. Henrique, Koen Bossers, Rogier M. Vos, et al.. (2013). Microarray and Morphological Analysis of Early Postnatal CRB2 Mutant Retinas on a Pure C57BL/6J Genetic Background. PLoS ONE. 8(12). e82532–e82532. 36 indexed citations

16.

Aartsen, Wendy M., Koen W. R. van Cleef, Lucie P. Pellissier, et al.. (2010). GFAP-Driven GFP Expression in Activated Mouse Müller Glial Cells Aligning Retinal Blood Vessels Following Intravitreal Injection of AAV2/6 Vectors. PLoS ONE. 5(8). e12387–e12387. 34 indexed citations

17.

Aartsen, Wendy M., Jean‐Pierre Arsanto, Jean‐Paul Chauvin, et al.. (2009). PSD95β regulates plasma membrane Ca(2+) pump localization at the photoreceptor synapse. Molecular and Cellular Neuroscience. 41(2). 156–165. 20 indexed citations

18.

Pavert, Serge A. van de, Wendy M. Aartsen, Rogier M. Vos, et al.. (2007). Crb1 is a determinant of retinal apical Müller glia cell features. Glia. 55(14). 1486–1497. 61 indexed citations

19.

Ferreira, Valérie, Ko Willems van Dijk, Albert K. Groen, et al.. (2006). Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation. Atherosclerosis. 192(2). 283–290. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact